4.5 Review Book Chapter

Vitamin A and Retinoic Acid in Cognition and Cognitive Disease

Journal

ANNUAL REVIEW OF NUTRITION, VOL 40, 2020
Volume 40, Issue -, Pages 247-272

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-nutr-122319-034227

Keywords

neuroplasticity; Alzheimer's disease; schizophrenia; autism; aging; hippocampus

Funding

  1. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/P004806/1]
  2. National Health Service (NHS) Grampian Endowments
  3. Intramural Research Program of the National Institutes of Health, National Institute on Aging
  4. BBSRC [BB/P004806/1] Funding Source: UKRI

Ask authors/readers for more resources

The history of vitamin A goes back over one hundred years, but our realization of its importance for the brain and cognition is much more recent. The brain is more efficient than other target tissues at converting vitamin A to retinoic acid (RA), which activates retinoic acid receptors (RARs). RARs regulate transcription, but their function in the cytoplasm to control nongenomic actions is also crucial. Controlled synthesis of RA is essential for regulating synaptic plasticity in regions of the brain involved in learning and memory, such as the hippocampus. Vitamin A deficiency results in a deterioration of these functions, and failure of RA signaling is perhaps associated with normal cognitive decline with age as well as with Alzheimer's disease. Further, several psychiatric and developmental disorders that disrupt cognition are also linked with vitamin A and point to their possible treatment with vitamin A or RA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available